615 related articles for article (PubMed ID: 29551551)
21. Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States.
Huhn AS; Hobelmann JG; Strickland JC; Oyler GA; Bergeria CL; Umbricht A; Dunn KE
JAMA Netw Open; 2020 Feb; 3(2):e1920843. PubMed ID: 32031650
[TBL] [Abstract][Full Text] [Related]
22. Clinical presentations, social functioning, and treatment receipt among individuals with comorbid life-time PTSD and alcohol use disorders versus drug use disorders: findings from NESARC-III.
Simpson TL; Rise P; Browne KC; Lehavot K; Kaysen D
Addiction; 2019 Jun; 114(6):983-993. PubMed ID: 30694592
[TBL] [Abstract][Full Text] [Related]
23. Medications for opioid use disorder among pregnant women referred by criminal justice agencies before and after Medicaid expansion: A retrospective study of admissions to treatment centers in the United States.
Winkelman TNA; Ford BR; Shlafer RJ; McWilliams A; Admon LK; Patrick SW
PLoS Med; 2020 May; 17(5):e1003119. PubMed ID: 32421717
[TBL] [Abstract][Full Text] [Related]
24. Medicaid expansion and treatment for opioid use disorders in Oregon: an interrupted time-series analysis.
McCarty D; Gu Y; McIlveen JW; Lind BK
Addict Sci Clin Pract; 2019 Aug; 14(1):31. PubMed ID: 31416475
[TBL] [Abstract][Full Text] [Related]
25. Predictors of treatment receipt among adults with a drug use disorder.
Epstein JF; Hourani LL; Heller DC
Am J Drug Alcohol Abuse; 2004 Nov; 30(4):841-69. PubMed ID: 15624552
[TBL] [Abstract][Full Text] [Related]
26. Prescription opioid misuse among middle-aged and older adults in the United States, 2015-2016.
Han BH; Sherman SE; Palamar JJ
Prev Med; 2019 Apr; 121():94-98. PubMed ID: 30763631
[TBL] [Abstract][Full Text] [Related]
27. The Relationship Between Residential Mobility and Behavioral Health Service Use in a National Sample of Adults With Mental Health and/or Substance Abuse Problems.
Yuan Y; Manuel JI
J Dual Diagn; 2018; 14(4):201-210. PubMed ID: 30303466
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis of Opioid Use Disorder by Youths Assessed in Acute Care Settings in British Columbia, Canada.
Krebs E; Zhou C; Min JE; Carter C; McGowan G; Nosyk B
J Pediatr; 2021 May; 232():243-250. PubMed ID: 33515555
[TBL] [Abstract][Full Text] [Related]
29. Patient characteristics associated with treatment initiation and engagement among individuals diagnosed with alcohol and other drug use disorders in emergency department and primary care settings.
Kline-Simon AH; Stumbo SP; Campbell CI; Binswanger IA; Weisner C; Haller IV; Hechter RC; Ahmedani BK; Lapham GT; Loree AM; Sterling SA; Yarborough BJH
Subst Abus; 2019; 40(3):278-284. PubMed ID: 30702983
[No Abstract] [Full Text] [Related]
30. Accessibility to Medication for Opioid Use Disorder After Interventions to Improve Prescribing Among Nonaddiction Clinics in the US Veterans Health Care System.
Hawkins EJ; Malte CA; Gordon AJ; Williams EC; Hagedorn HJ; Drexler K; Blanchard BE; Burden JL; Knoeppel J; Danner AN; Lott A; Liberto JG; Saxon AJ
JAMA Netw Open; 2021 Dec; 4(12):e2137238. PubMed ID: 34870679
[TBL] [Abstract][Full Text] [Related]
31. Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies.
Betts KS; Chan G; McIlwraith F; Dietze P; Whittaker E; Burns L; Alati R
Addiction; 2016 Jul; 111(7):1214-23. PubMed ID: 26857811
[TBL] [Abstract][Full Text] [Related]
32. Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: results from two national surveys.
McCabe SE; Cranford JA; West BT
Addict Behav; 2008 Oct; 33(10):1297-305. PubMed ID: 18632211
[TBL] [Abstract][Full Text] [Related]
33. Physical pain is common and associated with nonmedical prescription opioid use among people who inject drugs.
Dahlman D; Kral AH; Wenger L; Hakansson A; Novak SP
Subst Abuse Treat Prev Policy; 2017 May; 12(1):29. PubMed ID: 28558841
[TBL] [Abstract][Full Text] [Related]
34. National trends in substance use treatment admissions for opioid use disorder among adults experiencing homelessness.
Han BH; Doran KM; Krawczyk N
J Subst Abuse Treat; 2022 Jan; 132():108504. PubMed ID: 34102461
[TBL] [Abstract][Full Text] [Related]
35. Use of specialty substance abuse and mental health services in adults with substance use disorders in the community.
Mojtabai R
Drug Alcohol Depend; 2005 Jun; 78(3):345-54. PubMed ID: 15893166
[TBL] [Abstract][Full Text] [Related]
36. Functional and structural social support, substance use and sexual orientation from a nationally representative sample of US adults.
Kahle EM; Veliz P; McCabe SE; Boyd CJ
Addiction; 2020 Mar; 115(3):546-558. PubMed ID: 31599027
[TBL] [Abstract][Full Text] [Related]
37. Persistence/recurrence of and remission from DSM-5 substance use disorders in the United States: Substance-specific and substance-aggregated correlates.
McCabe SE; West BT; Strobbe S; Boyd CJ
J Subst Abuse Treat; 2018 Oct; 93():38-48. PubMed ID: 30126540
[TBL] [Abstract][Full Text] [Related]
38. Trends and disparities in receipt of pharmacotherapy among pregnant women in publically funded treatment programs for opioid use disorder in the United States.
Short VL; Hand DJ; MacAfee L; Abatemarco DJ; Terplan M
J Subst Abuse Treat; 2018 Jun; 89():67-74. PubMed ID: 29706175
[TBL] [Abstract][Full Text] [Related]
39. National Trends in Mental Health Care for US Adolescents.
Mojtabai R; Olfson M
JAMA Psychiatry; 2020 Jul; 77(7):703-714. PubMed ID: 32211824
[TBL] [Abstract][Full Text] [Related]
40. Regular outpatient medical and drug abuse care and subsequent hospitalization of persons who use illicit drugs.
Laine C; Hauck WW; Gourevitch MN; Rothman J; Cohen A; Turner BJ
JAMA; 2001 May; 285(18):2355-62. PubMed ID: 11343483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
